Patents by Inventor Kanako AMANO

Kanako AMANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHORT-CHAIN CPG-CONTAINING OLIGODEOXYNUCLEOTIDE WITH LINKED POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE THEREOF
    Publication number: 20230053708
    Abstract: The present invention provides an oligodeoxynucleotide which comprises a CpG oligodeoxynucleotide comprising a nucleotide sequence represented by formula (1): 5?X-CpG-L-CpG-TZ3???(I) wherein X is T or C, L is a nucleotide sequence consisting of 1 to 7 bases, and Z is T or C, and consisting of 8 to 16 bases, and a polydeoxyadenylic acid having a length capable of forming a complex with a ?-1,3-glucan, wherein the polydeoxyadenylic acid is linked to the 3? side of the CpG oligodeoxynucleotide. In addition, the present invention provides a complex containing said oligodeoxynucleotide and a ?-1,3-glucan.
    Type: Application
    Filed: December 24, 2020
    Publication date: February 23, 2023
    Applicant: NapaJen Pharma, Inc.
    Inventors: Kanako AMANO, Atsushi UNO
  • CANCER CELL ADHESION ACTIVITY INHIBITOR
    Publication number: 20200038428
    Abstract: The purpose of the present invention is to provide a drug that is capable of effectively inhibiting adhesion activity, growth, and engraftment of cancer cells, using an oligodeoxynucleotide (ODN) in which phosphodiester bonds are phosphorothioated (S-configured). Adhesion activity, growth inhibitory capacity, and engraftment inhibitory capacity of cancer cells are rapidly improved as a result of S-configured ODN being formed into a composite with a polysaccharide having a ?-1,3-glucan backbone.
    Type: Application
    Filed: March 22, 2018
    Publication date: February 6, 2020
    Applicant: NAPAJEN PHARMA, INC.
    Inventors: Sadaharu HIGUCHI, Kanako AMANO, Maki Ushida, Hironori ANDO